Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AMICUS THERAPEUTICS, INC. Director's Dealing 2019

May 17, 2019

31523_dirs_2019-05-17_3dc6fab6-389a-40ae-abf0-030e60d598be.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2019-05-10

Reporting Person: WHITMAN BURKE W (Director)

Holdings (Non-Derivative)

Security Shares Ownership
No Securities Beneficially Owned 0 Direct